MICs of the new fluoroquinolone drugs ofloxacin, ciprofloxacin, and sparfloxacin (AT-4140) for 10 strains of Mycobacterium tuberculosis were determined by using both a BACTEC radiometric method and testing on solid 7H11 agar medium. Radiometric MICs by 7H12 broth testing ranged from 0.5 to 1.0, 0.25 to 0.5, and 0.1 to 0.2 ,ug/ml for ofloxacin, ciprofloxacin, and sparfloxacin respectively, whereas MICs in solid medium ranged from 0.5 to 1.0, 0.5 to 1.0, and 0.2 to 0.5 ,ug/ml, respectively. The bactericidal action of the quinolones compared with their reported peak concentrations in human serum showed that sparfloxacin is the most bactericidal, followed by ciprofloxacin and ofloxacin. Our results suggest the potential of the new difluorinated quinolone sparfloxacin for use against the tubercle bacillus and indicate that further determination of its antimycobacterial spectrum and intracellular efficacy may be fruitful.
The new fluoroquinolones are potent synthetic antibacterial agents with broad spectra of activity, including activity against mycobacteria (6) . Among many of the newer fluoroquinolones tested against mycobacteria, both the N-cyclopropyl analog ciprofloxacin and the tricyclic compound ofloxacin showed the highest activities against Mycobacterium tuberculosis (1, 2, 4, 11) , were found to penetrate and actively concentrate inside mammalian cells (3, 5, 15) , and were bactericidal against intracellularly growing tubercle bacilli (9) .
Recently, a new difluorinated quinolone, sparfloxacin [AT-4140; 5 amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-(7 cis-3,5-dimethyl-1-piperazinyl)-4-oxoquinolone-3-carboxylic acid] was shown to possess a broad spectrum of activity, with in vitro activity and in vivo efficacy that were equal to or better than those of ofloxacin and ciprofloxacin (8) . Its in vitro activity against the Mycobacterium avium complex was found to be greater than that of ciprofloxacin (17) . In experiments involving animals, sparfloxacin was shown to achieve levels in tissues of mice and rats which were 2 to 11 times higher than the concentrations in plasma (7) . Following these observations, we decided to assess the antitubercle bacilli activity of sparfloxacin in comparison with those of ofloxacin and ciprofloxacin. We intentionally decided to screen drug concentrations well below the concentrations achievable in human serum so that any bactericidal action obtained at these concentrations might reflect clinically relevant activity.
Ten strains of M. tuberculosis (the type strain H37Rv and nine recent clinical isolates) were selected for use in this study.
For MIC determinations with solid medium, bacteria from Lowenstein-Jensen slants were harvested and thoroughly homogenized by shaking them in sterile distilled water with 2-mm-diameter glass beads. The optical density at 650 nm of the bacterial suspension was adjusted to 0.15 (using a Coleman junior II spectrophotometer, which corresponded to about 108 viable counts per ml), and appropriate dilutions * Corresponding author.
were then plated onto 7H11 agar containing increasing concentrations of the drugs. The CFU per milliliter was determined after incubation at 37°C for 21 days, and the MIC was defined as the lowest concentration of drug which caused at least a 99% reduction in viable counts compared with those of drug-free controls (11) .
For radiometric studies with the BACTEC 460-TB system (Becton Dickinson, Towson, Md.), bacterial growth in a confined atmosphere was measured as a function of the ability of the bacteria to catabolize 14C-labeled palmitic acid in 7H12 broth, which resulted in the liberation of 14C02 (14) .
The growth in terms of the amount of CO2 liberated was expressed as a numerical value called the growth index (GI), which ranged from 1 to 999. Radiometric determination of MICs was performed as reported earlier (12, 14) , with some modifications. Briefly, 0.1 ml of the suspension from a fresh primary culture of bacteria in 7H12 broth (grown to a GI of about 500) was injected into control and drug-containing vials. Daily GI values were recorded and compared with the GI of a second control vial which was inoculated with 0.1 ml of a 100-fold diluted bacterial suspension (10-2 control) . Results were read once the GI in the 10-2 control reached a value of 30 or more (usually 7 days). The MIC was defined as the minimal drug concentration resulting in a lesser change in the GI in the drug-containing sample compared with that in the 10-2 control. The bactericidal action of the drugs was determined as follows. A total of 0.1 ml of culture from the BACTEC vials was removed and successively diluted 10-fold in sterile double-distilled water to give dilutions of 10-1, 10-2, 10-3, and 10-'. A total of 0.1 ml each of these dilutions was plated onto 7H11 agar medium, and the resulting CFU per milliliter was enumerated after 21 days of incubation at 37°C (10, 13 mined by using 7H11 agar medium and BACTEC radiometric methods for all of the 10 strains of M. tuberculosis are summarized in Table 1 . GI values obtained for four of these strains are illustrated in Fig. 1 for reference. MICs of ofloxacin, ciprofloxacin, and sparfloxacin obtained with 7H12 broth by BACTEC radiometry ranged from 0.5 to 1.0, 0.25 to 0.5, and 0.1 to 0.2 ,ug/ml, respectively. The MICs of these quinolones obtained with the solid medium were equal to or slightly higher than those observed with 7H12 broth and ranged from 0.5 to 1.0, 0.5 to 1.0, and 0.2 to 0.5 ,ug/ml, respectively ( Table 1 ). The radiometric growth inhibitory action of the quinolones at their MICs is illustrated in Fig. 1 for four strains. It should be emphasized that these MICs are below the peak concentrations of the drugs in human serum (Cmax), i.e., about 10 and 3 ,i.g/ml for ofloxacin and ciprofloxacin, respectively (16), and 1.4 p.g/ml for sparfloxacin (8) .
Results describing the bactericidal action of ofloxacin, ciprofloxacin, and sparfloxacin are summarized in Table 2 . In these experiments, the highest drug concentration used was chosen to be 3 to 5 times less than the reported Cmax values for each drug in humans.
These results showed that, in contrast to previous results obtained with M. avium, for which MICs of ofloxacin (between 4 and >32 ,xg/ml [4] ), ciprofloxacin (0.5 to 16 ,ug/ml [4] ), and sparfloxacin (1 to >4 ,g/ml for the majority of strains [17] ) were much higher, MICs of these three fluoroquinolones were much lower and were within a very narrow range for the M. tuberculosis strains tested. Furthermore, when compared with the MBCs of these fluoroquinolones against M. avium, i.e., 16 to 512 ,ug/ml for ofloxacin and 4 to 64 ,ug/ml for ciprofloxacin (4) and >4 ,ug/ml (highest concentration tested) for sparfloxacin (17) , our results show that all the fluoroquinolones tested were significantly more bactericidal against all M. tuberculosis strains tested, with MIC/ MBC ratios of 1/2 in the case of ciprofloxacin, 1/1 to 1/2 in the case of sparfloxacin, and 1/2 or more in the case of ofloxacin. The results for ofloxacin and ciprofloxacin obtained in this study are in agreement with previously published data (4). As is clear from Table 2 , sparfloxacin at 0.5 ,ug was the most bactericidal of the three quinolones.
None of these quinolones has been approved for use against M. tuberculosis, and consequently, it is difficult to assess the results in terms of their concentrations in human serum. However, if our data are interpreted in terms of the bactericidal action achieved compared with the reported Cmax of the quinolones tested, it can be stated that sparfloxacin and ciprofloxacin are more bactericidal than ofloxacin. We thus conclude that the newly synthesized difluorinated quinolone sparfloxacin is highly bactericidal against M. tuberculosis, and testing of its extracellular and intracellular activities against a wide range of pathogenic mycobacteria should be undertaken.
